Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV)

The US Food and Drug Administration issued a black box warning related to the risk of reactivation of overt/occult hepatitis B virus (HBV) infection during direct acting-antivirals (DAA) treatment. This review evaluated the prevalence of HBV reactivation after hepatitis C virus (HCV) pharmacological...

Full description

Saved in:
Bibliographic Details
Published in:Viruses
Main Authors: Pisaturo, Mariantonietta, Macera, Margherita, Alessio, Loredana, Calò, Federica, Coppola, Nicola
Format: Artigo
Language:Inglês
Published: MDPI 2019
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6784257/
https://ncbi.nlm.nih.gov/pubmed/31540223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v11090850
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items